Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 2 9Phase NA 5Phase 1 4Phase 1/2 2

Status

Completed 29Recruiting 5Terminated 4Withdrawn 1Unknown 1Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4Gastrointestinal 4Thoracic 1Head & Neck 1

Conditions

Neoplasms 282Carcinoma, Non-Small-Cell Lung 253Leukemia, Myeloid, Acute 190Breast Neoplasms 153Melanoma 151Neoplasm Metastasis 148Multiple Myeloma 127Recurrence 123Colorectal Neoplasms 119Lymphoma, Non-Hodgkin 114Lymphoma 113Leukemia, Lymphocytic, Chronic, B-Cell 108Pancreatic Neoplasms 99Ovarian Neoplasms 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 91Leukemia 86Prostatic Neoplasms 83Lung Neoplasms 82Lymphoma, Large B-Cell, Diffuse 77Squamous Cell Carcinoma of Head and Neck 76Glioblastoma 73Carcinoma, Renal Cell 72Myelodysplastic Syndromes 68Lymphoma, Follicular 65Brain Neoplasms 60Lymphoma, Mantle-Cell 55Sarcoma 53Stomach Neoplasms 52Head and Neck Neoplasms 52Triple Negative Breast Neoplasms 51

Interventions

spartalizumab 1ribociclib 1Sunitinib 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Gastrointestinal Stromal Tumors × Clear all
NCT04000529 2025-09-30

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Novartis

Phase 1 Terminated
122 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT04276415 2024-02-15

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

Daiichi Sankyo

Phase 1 Terminated
34 enrolled 27 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02185937 2020-12-08

ABILITY

Radboud University Medical Center

Phase 1 Terminated
5 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00573404 2011-11-16

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Vanderbilt-Ingram Cancer Center

Phase 1 Terminated
6 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡